- Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
-
Tan DS, Chan JJ, Hettle R, Ghosh W, Viswambaram A, Yu CC
- KMID: 2526375
- J Gynecol Oncol.
- 2021 Mar;32(2):e27.
- doi: 10.3802/jgo.2021.32.e27
Objective: To evaluate the cost-effectiveness of olaparib as a maintenance treatment versus routine surveillance (RS) in patients with BRCA mutated (BRCAm) advanced ovarian cancer (OC) following response to first-line platinum-based... -
- CITED
-
- Close
- SHARE
-
- Close
